コンテンツメニュー

Matsui Hiroto

Affiliate Master Yamaguchi University

A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer

Journal of Immunotherapy : official journal of the Society for Biological Therapy Volume 37 Issue 1 Page 36-42
published_at 2014-01
Title
A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer
Creators Suzuki Nobuaki
Creators Hazama Shoichi
Creators Ueno Tomio
Creators Matsui Hiroto
Affiliate Master Yamaguchi University
[kakenhi]15501 grid.268397.1
Creators Shindo Yoshitaro
Creators Iida Michihisa
Creators Yoshimura Kiyoshi
Creators Yoshino Shigefumi
Creators Takeda Kazuyoshi
Creators Oka Masaaki
Creator Keywords
pancreatic cancer peptide KIF20A phase I immunotherapy
Languages eng
Resource Type journal article
Publishers Raven Press Lippincott Williams & Wilkins
Date Issued 2014-01
File Version Not Applicable (or Unknown)
Access Rights metadata only access
Relations
[ISSN]1524-9557
[NCID]AA10794609
[NCID]AA12551619
[PMID]info:pmid/24316554
info:doi/10.1097/CJI.0000000000000012
[isVersionOf] [URI]http://journals.lww.com/immunotherapy-journal/pages/default.aspx
Schools 大学院医学系研究科(医学) 医学部附属病院